Drug intelligence / Profile preview

lidocaine + bupivacaine + epinephrine

Development stage
Phase 4
Lead developer
NYU Langone Health
Modality
Small Molecules
Administration
Perineural
01

Overview

Ankle SSB is a specific regional anesthetic combination used for single-shot peripheral nerve blocks to manage postoperative pain following ankle fracture surgery. Developed and studied by NYU Langone Health, this formulation consists of a mixture of lidocaine (a fast-acting local anesthetic), bupivacaine (a long-acting local anesthetic), and epinephrine (a vasoconstrictor used to prolong the block's duration and reduce systemic absorption). It is typically administered via injection around the target nerves to provide immediate and sustained analgesia during the early postoperative period. The combination leverages the rapid onset of lidocaine and the extended duration of bupivacaine, while epinephrine enhances the efficacy and safety profile by localizing the drugs at the site of injection.

Other names
Single Shot Peripheral Nerve Block
02

Targets

ADRA1A (α1A)ADRA2A (α2A)ADRB1 (β1)ADRB2 (β2)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)SCN3A (Sodium channel protein type 3 subunit alpha)SCN4A (Voltage-gated sodium channel protein type 4 subunit alpha)SCN5A (Sodium channel protein type 5 subunit alpha)SCN8A (NaV1.6)SCN9A (Sodium channel protein type 9 subunit alpha)

Beyond the preview

Go deeper on lidocaine + bupivacaine + epinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + bupivacaine + epinephrine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call